News & Analysis as of

Title IV Innovation

MoFo Life Sciences

CURES 2.0: WILL IT BE BETTER THAN THE ORIGINAL?

MoFo Life Sciences on

It’s summer blockbuster season and that means sequels abound. Now it seems that the U.S. Congress wants in on the action. Just five years after Congress passed the 21st Century Cures Act, a bipartisan group of...more

Hogan Lovells

Department of Education convenes "Accreditation and Innovation" negotiated rulemaking committee

Hogan Lovells on

The U.S. Department of Education (ED) will convene a negotiated rulemaking committee in Washington, D.C. 14-16 January 2019 to begin discussions about proposals to revise the ED regulations related to the Title IV federal...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide